CASE STUDY VEROVACCINES PUBLISHED IN ‘GOING PUBLIC’ MAGAZINE/WEBPAGE

The capital market portal/magazine ‘Going Public’ published a case study about Verovaccines, its technology, the unique access to generate vaccines against the ever increasing variants of rapidly changing pathogens (e.g. influenza), Verovacines’ products and economic potential.